Transient Choroidal Thinning after Intravitreal Bevacizumab Injection for Myopic Choroidal Neovascularization
نویسندگان
چکیده
منابع مشابه
Single intravitreal ranibizumab for myopic choroidal neovascularization
We report a case of myopic choroidal neovascularization that showed improvement after a single injection of ranibizumab. A 45-year-old Chinese man with high myopia presented with sudden onset painless central scotoma of his right eye of 2 weeks' duration. There was no history of trauma. His right eye vision on presentation was 6/30 which showed no improvement with pinhole. The right fundus show...
متن کاملIntravitreal Injection of Bevacizumab for Myopic Choroidal Neovascularization, Is It Valuable?
Introduction: Subfoveal choroidal neovascularization (CNV) is a devastating complication of pathological myopia leading to immediate and potentially irreversible vision loss. Although several treatments including thermal laser photocoagulation, photodynamic therapy, macular translocation and surgical removal of CNV, have been attempted to this disease, the beneficial effects are questionable be...
متن کاملIntravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization.
To report a patient with juxtapapillary choroidal osteoma (CO) with serous retinal detachment (SRD) not associated with choroidal neovascularization (CNV) who was successfully treated with a single intravitreal injection of bevacizumab. A 20-year-old woman presented with decreased vision in her right eye. Ultrasonography, fundus autofluorescence, fluorescein angiography (FA) and optical coheren...
متن کاملIntravitreal bevacizumab for subfoveal idiopathic choroidal neovascularization.
OBJECTIVES To evaluate the short-term visual and anatomical outcomes and safety of intravitreal bevacizumab in subfoveal idiopathic choroidal neovascularization. METHODS Thirty-two eyes of 32 patients with idiopathic choroidal neovascularization received intravitreal bevacizumab (1.25 mg/0.05 mL) in this prospective, noncomparative, interventional case series. Injection was repeated if optica...
متن کاملOnly first intravitreal bevacizumab injection achieves statistically significant visual improvement in naïve myopic choroidal neovascularization
BACKGROUND The aim of this study was to evaluate the efficacy of intravitreal bevacizumab when administered on an as-needed basis for the treatment of myopic choroidal neovascularization (CNV), and to assess visual changes upon treatment. METHODS This study was designed as a retrospective, interventional case series, for which the inclusion criteria were pathologic myopia, and documentation o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical & Experimental Ophthalmology
سال: 2011
ISSN: 2155-9570
DOI: 10.4172/2155-9570.1000165